Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) shares, rose in value on Friday, June 20, with the stock price down by -1.17% to the previous day’s close as strong demand from buyers drove the stock to $0.25. Actively observing the price movement in the last trading, the
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) concluded the trading at $0.28 on Friday, June 06 with a fall of -1.01% from its closing price on previous day. Considering stock’s 52-week price range provides that ADAP hit a high price of $1.48 and saw its price falling
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) shares, rose in value on Friday, May 30, with the stock price up by 7.10% to the previous day’s close as strong demand from buyers drove the stock to $0.29. Actively observing the price movement in the last trading, the
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) traded at $0.28 at last check on current trade day and made a downward move of -6.00% on its previous day’s price. Adaptimmune Therapeutics Plc ADR has a market cap of $71.02 million and is expected to release its quarterly
The trading price of Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) closed lower on Tuesday, May 06, and closing at $0.30, -0.89% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $1.48 and a 52-week
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.